Neurafarm
PrivateLast Round
Early Funding
Mar 17, 2025
Total Funding Raised
$4.27M
Company Overview
Neurafarm is an agritech company that provides an AI-powered crop protection and management platform to help farmers improve productivity and efficiency.
Sector
AI, Data & Cloud Infrastructure
Verticals
Computer Vision, NLP & Conversational AI, Environmental Monitoring, Vertical SaaS
Business Model
B2C
Customer Profile
Freemium, Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurafarm Comparables
Compare Neurafarm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Agrio | 83% | |
| AgriPredict | 77% | |
| HELM AG | 71% |
Neurafarm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 17, 2025 | ||||
| Grant | Mar 20, 2021 |
Neurafarm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Intudo Ventures | Early Funding |
| 500 Global | Early Funding |
| Singapore International Foundation | Grant |
| Insignia Ventures Partners | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors grew 309% MoM, reaching 19.8K.
- Mar 17, 2025
$4.25M raised, led by Intudo Ventures.
Neurafarm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neurafarm's valuation, stock price, and market status.
Is Neurafarm a public or private company?
Neurafarm is a private company.
What is the current stock price of Neurafarm?
Neurafarm is a private company with no public stock price. Caplight tracks Neurafarm's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Neurafarm worth (valuation)?
Valuation information for Neurafarm is not publicly available.
Can I buy Neurafarm stock?
Neurafarm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neurafarm's last funding round?
Neurafarm's most recent funding round was Early Funding on March 17, 2025.
Who are the main investors in Neurafarm?
Key investors in Neurafarm include Intudo Ventures.
Will Neurafarm IPO soon?
No public IPO plans have been announced for Neurafarm.
How can I track Neurafarm secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neurafarm's secondary market activity and sign up for updates.